JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by STOUGHTON, R. W.
Right arrow Articles by BAXTER, J. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by STOUGHTON, R. W.
Right arrow Articles by BAXTER, J. H., JR.
Journal of Pharmacology And Experimental Therapeutics, Vol. 73, Issue 1, 45-50, 1941
Copyright © 1941 by American Society for Pharmacology and Experimental Therapeutics


HYPNOTIC ACTION OF 5,5-DIALKYL-2,4-OXAZOLIDINEDIONES WITH SPECIAL REFERENCE TO 5,5-DI-n-PROPYL-2,4-OXAZOLIDINEDIONE

ROGER W. STOUGHTON 1 and J. H. BAXTER JR. 1

1 From the Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee

A series of new chemical compounds, the 5,5-dialkyl-2,4-oxazolidinediones, has been presented which exhibits hypnotic action. Their relative anesthetic activity in white mice has been evaluated. The anesthesia produced was usually of brief duration with rapid recovery.

5,5-Di-n-propyl-2,4-oxazolidinedione has been given intravenously, orally and by rectum to a series of animals in varying doses over different periods of time. All degrees of anesthesia and hypnosis have been produced by this substance. On the intravenous administration of full anesthetic doses to dogs, the period of anesthesia was relatively short, but was followed by a period of hypnosis which might last for 60 or 70 hours. A careful study of the reaction of the animals to this substance has been made and no contraindications to its trial in man have thus far been discovered. It has been given to a small series of patients without ill-effects and appears to deserve further clinical trial.

Submitted on May 26, 1941







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1941 by the American Society for Pharmacology and Experimental Therapeutics.